The Biomedical Engineering Society (BMES) Boston Industry Chapter &

 the Charles Stark Draper Laboratory presents:

 

Smart Medical Devices Panel Discussion

Monday, February 8th, 6:00 - 8:30 PM

Event Sponsored by the Charles Stark Draper Laboratory

The demand for better healthcare outcomes at lower costs is likely to increase over the next several years.  One solution to this need will be Smart Medical Devices (SMDs), devices that sense key clinical parameters important to clinicians, analyze these data and implement results - either with clinical guidance or closed-loop.  While some SMD-like devices already exist, there is tremendous opportunity for innovation.  Over the course of the evening, the panel of engineering, clinical and industry experts will provide a view into the current status and future directions for SMDs.

 

When:    Monday, February 8^th

Time:      6:00 pm - 8:30 pm

Where:  Charles Stark Draper Laboratory

1 Hampshire Street, Cambridge, Ma

 

Agenda:

6:00 - 6:30pm -                     Registration/Networking/ Appetizers

6:30 - 6:45 pm -                    Opening Remarks, BMES Leadership Team

6:45 - 8:00 pm -                    Panel: "Smart Medical Devices"

8:00- 8:30 pm -                    Networking/Refreshments/Desserts

 

Panelists:

• Edward Kerslake, Vice President, Corporate Technology Development, Boston Scientific
• Dale Larson, Director of the Biomedical Systems Group, Charles Stark Draper Laboratory
• Dr. David Rattner, Chief of the Division of General and Gastrointestinal Surgery, Massachusetts General Hospital

 

Event Fee:

Early Bird:                              $10 by January 27th

Regular Deadline:                $15 by February 3rd

On-site registration:           $20 (highly discouraged)

Register Today!                    Click Here

 

About our Panelists:

 

Edward Kerslake, Vice President Portfolio Management, Corporate R&D at Boston Scientific

 

Dr. Kerslake leads Boston Scientific's R&D portfolio management process and the company's efforts to ensure disciplined execution of its committed investments. Dr. Kerslake most recently held the position of EVP & COO at MDdatacor, an innovative venture-backed cardiology company based in Atlanta, GA and started by the founder of WebMD. Previously, he was a Senior Leader at The Monitor Group, a global strategy consulting firm, where his practice addressed the creation and architecture of corporate and R&D strategies with clients in the pharmaceutical, device and broader life sciences. Before Monitor, Dr. Kerslake worked in the pharmaceutical industry as Senior Scientist and as Head of Formulation for Allergan (NYSE:AGN) at its European R&D Headquarters in the south of France, the R&D/manufacturing facility in Italy, and subsequently at its headquarters in California. While at Allergan, Dr Kerslake invented and holds the patents protecting Allergan's Alphagan P Glaucoma portfolio (a ~$400M/yr suite of products). Qualified as a pharmacist in the UK, Dr. Kerslake subsequently received a Ph.D. in Pharmaceutical Sciences (Controlled Drug Delivery - Transdermal Systems) and an M.B.A. from the University of California-Irvine.

 

Dale Larson, Director of the Biomedical Systems Group, Charles Stark Draper Laboratory

 

Dale Larson is the Director of the Biomedical Systems Group at the Charles Stark Draper Laboratory.  Before joining Draper, Larson spent more than seven years at Harvard Medical School, where he was the founding director of its Technology & Engineering Center-a group that has been pioneering in the development of a variety of clinical diagnostics and advanced instrumentation for the life sciences. With previous tenures at companies including Arthur D. Little, Genomics Collaborative, Ortho Diagnostics Systems and Thermedics, Inc. and AT&T Bell Laboratories, he has industry experience in the areas of genomics services, instrumentation, clinical diagnostics, medical devices, and explosives detection.

 

Dr. David Rattner, Chief of the Division of General and Gastrointestinal Surgery, MGH

David Rattner received his medical degree from the Johns Hopkins School of Medicine. After completing his residency in surgery at the Massachusetts General Hospital, he joined the active clinical faculty, where he is now Chief of the Division of General and Gastrointestinal Surgery. In addition to pursuing research on minimally invasive surgery and technology transfer, Dr. Rattner is a Professor of Surgery at Harvard Medical School. He has published over 150 original articles concerning pancreatic disease and biliary disease, gastroesophageal reflux disease, and minimally invasive therapy.

 

About Our Sponsor: Charles Stark Draper Laboratory

Headquartered in Cambridge, Massachusetts, Draper Laboratory is a research and development laboratory, employing more than 850 engineers, scientists, and technicians on a broad array of programs for government and commercial sponsors among its 1,384 employees.

Its sponsored work encompasses capabilities in the following business areas:

• Strategic Systems
• Space Systems
• Tactical Systems
• Special Operations
• Biomedical Engineering
• Geospatial Solutions
• Energy Solutions

 

The Laboratory's unparalleled expertise in the areas of guidance, navigation, and control systems remains its greatest resource. Draper is among the leaders in fault-tolerant computing, reliable software development, modeling and simulation, and MEMS technology. It applies its expertise to a broad range of domains, including autonomous air, land, sea, and space systems; information integration; distributed sensors and networks; precision-guided munitions; air traffic flow management; military logistics; and biomedical engineering and chemical/biological defense.

 

About Our Chapter:

The Biomedical Engineering Society, Boston Industry Chapter, was founded in October 2008 to develop a community that provides Biomedical Engineering (BME) professionals with networking, continuing education, and technology transfer opportunities.  Our mission is to serve as the lead society for BME professionals, expand the careers of current and next generation BMEs, educate the technical community regarding the expertise BMEs provide to engineering and scientific field, and enhance the recognition of biomedical engineering as a discipline critical to the continued improvement of human health. Check out our website: http://www.bmes.org/mc/page.do?sitePageId=71380&orgId=bes . Please contact Andrea Ippolito (bmesprofessional@gmail.com) if you have any questions.

 

Mission of the Biomedical Engineering Society, Boston Industry Chapter:

• To serve as the lead society for BME professionals
• To expand the careers of current and next generation BMEs
• To educate the technical community regarding the expertise BMEs provide to engineering and scientific fields
• To enhance the recognition of biomedical engineering as a discipline critical to the continued improvement of human health

 

Contact Andrea Ippolito (bmesprofessional@gmail.com) if you have any questions or BMES office at regina.borkoski@bmes.org.

 

Directions:

http://draper.com/directions/directions.html

Parking is available in the Technology Square garage across from the Draper visitor entrance. It is the second garage entrance on the right from the Broadway entrance to Tech Square.